OKYO Pharma LTD
22.7.2026 13:00:00 CEST | Globenewswire | Press release
OKYO Pharma Announces Purchase of Shares by Chief Medical Officer
OKYO Pharma Announces Purchase of Shares by Chief Medical Officer
LONDON and NEW YORK, July 22, 2026 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, today announced that OKYO Pharma’s Chief Medical Officer, Flavio Mantelli, MD, PhD, has purchased 20,000 of the Company’s ordinary shares on NASDAQ at $1.40 per share.
About OKYO Pharma
OKYO Pharma Limited (Nasdaq: OKYO) is a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP) and anterior segment eye diseases, with ordinary shares listed for trading on the Nasdaq Capital Market. OKYO plans to initiate a global Phase 3 pivotal clinical trial in the second half of this year, enrolling approximately 111 patients to evaluate a single-dose regimen of urcosimod for the treatment of NCP.
For further information, please visit www.okyopharma.com.
For further inquiries:
OKYO Pharma Ltd
Paul Spencer
Business Development and Investor Relations
+44 (0) 207 495 2379
Email: info@okyopharma.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Brødrene A. & O. Johansen A/S22.7.2026 15:05:00 CEST | Press release
Brødrene A. & O. Johansen A/S receives regulatory approval from the Norwegian Competition Authority in relation to its recommended voluntary cash offer for Elektroimportøren AS
Brødrene A. & O. Johansen A/S22.7.2026 15:05:00 CEST | Pressemeddelelse
Brødrene A. & O. Johansen A/S modtager myndighedsgodkendelse fra den norske konkurrencemyndighed i forbindelse med sit anbefalede frivillige kontante overtagelsestilbud på Elektroimportøren AS
Mavenir Systems, Inc.22.7.2026 15:00:00 CEST | Press release
Mavenir Rated Very Strong in GlobalData's 2026 IMS and Voice Core Competitive Landscape Assessment
Alira Health22.7.2026 15:00:00 CEST | Press release
Specialized Manufacturing Capability Emerges as the New Competitive Advantage in the $23.2 Billion Global Biologics CDMO Market, Finds Alira Health
Zoom Communications, Inc.22.7.2026 15:00:00 CEST | Press release
Zoom Revenue Accelerator unveils AI that drives revenue action, not just insights
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom